Spring time...ARVO time
...spring time is arrived here in Switzerland. With the blossoming of the cherry trees it comes also ARVO, one of the leading conferences for the Ophthalmology community. This year dedicated to the journey "From bench to bedside and back". Intriguing.
Our team here at Roche and Genentech will be presenting new exciting results on the use of Artificial Intelligence to predict diabetic retinopathy disease progression at the individual patient level. Predicting disease progression and identifying slow and fast progressors is paramount to enable clinical trial of novel therapies capable to preserve vision even at earlier stages of disease.
If you have time and you are curious, please, stop at our poster, you're welcome: PB093 - Deep Learning Algorithm to Predict Diabetic Retinopathy